Guglielmo Di Molfetta
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Prognostic Added Value of GFAP in Patients With Minor Ischemic Stroke.
Journal: European journal of clinical investigation
Published: January 27, 2026
Plasma Proteomic Changes in GRN and C9orf72 Frontotemporal Dementia.
Journal: European journal of neurology
Published: January 08, 2026
Diagnostic performance of plasma GFAP in preclinical stages of Alzheimer's disease using the Lumipulse platform.
Journal: Alzheimer's research & therapy
Published: November 11, 2025
Long-COVID: assessment of circulating markers suggests no cerebral neuronal damage, neuroinflammation or systemic inflammation-a controlled study.
Journal: Scientific reports
Published: October 06, 2025
Plasma p-tau217 and glucose metabolism correlate in neocortical association areas in Alzheimer's disease.
Journal: Brain communications
Published: August 25, 2025
Plasma p-tau217 as a biomarker of Alzheimer's disease pathology in individuals with Down syndrome.
Journal: Nature communications
Published: July 23, 2025
Glia inflammation and cell death pathways drive disease progression in preclinical and early AD.
Journal: EMBO molecular medicine
Published: June 17, 2025
Profiling Plasma Biomarkers, Particularly pTau217 and pTau217/Aβ42, and Their Relation to Cognition in Memory Clinic Patients.
Journal: Journal of neurochemistry
Published: April 29, 2025
Prevalence of Alzheimer's disease pathology in the community.
Journal: Nature
Published: March 04, 2025
Biofluid-based staging of Alzheimer's disease.
Journal: Acta neuropathologica
Published: November 06, 2024
Last Updated: 09/26/2026